Recruiting Idiopathic Thrombocytopenic Purpura Studies in Denver
About Idiopathic Thrombocytopenic Purpura Clinical Trials in Denver
Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.
There are currently 1 idiopathic thrombocytopenic purpura clinical trials recruiting participants in Denver, COLORADO. These studies are seeking a combined 171 participants. Research is being sponsored by Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Idiopathic Thrombocytopenic Purpura Clinical Trials in Denver — FAQ
Are there idiopathic thrombocytopenic purpura clinical trials in Denver?
Yes, there are 1 idiopathic thrombocytopenic purpura clinical trials currently recruiting in Denver, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Denver?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Denver research site will contact you about next steps.
Are clinical trials in Denver free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Denver studies also compensate for your time and travel.
What idiopathic thrombocytopenic purpura treatments are being tested?
The 1 active trials in Denver are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.
Data updated March 2, 2026 from ClinicalTrials.gov